MFG
AMPH icon

Mendota Financial Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Mendota Financial Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,426
Closed -$127K – 126
2024
Q4 		$127K Sell
3,426
-1,081
-24% -$49.4K 0.08% 65
2024
Q3 		$219K Buy
4,507
+3
+0.1% +$132 0.1% 49
2024
Q2 		$180K Buy
+4,504
New +$187K 0.1% 62

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mendota Financial Group's AMPH Position: Q1 2025 in Review

Mendota Financial Group sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 3,426 shares — an estimated $127K sold.

Mendota Financial Group first reported a position in AMPH in Q2 2024 and held it in 3 quarters. The position peaked at $219K in Q3 2024. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

  • Mendota Financial Group reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Mendota Financial Group sold 3,426 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $127K.
  • Mendota Financial Group first reported a position in Amphastar Pharmaceuticals in Q2 2024 and held it in 3 quarters.
  • Mendota Financial Group's Amphastar Pharmaceuticals position peaked at $219K in Q3 2024.
  • 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on Mendota Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.